Study on Immunomodulatory Action of Suvarna Prashana on Recurrent Upper Respiratory Tract Infection in Children.

Study on Immunomodulatory Action of Suvarna Prashana on Recurrent Upper Respiratory Tract Infection in Children-A Two Arm Prospective Randomized controlled Trial Study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034161

Enrollment

Registered

2021-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Suvarna Prashana: In Group A Suvarna Prashana Will be Administered Once Daily in 1-5 year old children for 45 days continue. Control Intervention1: Placebo Drug(Madhu & Ghrita): Dose -

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of age group of 1 to 5 years of either sex will be selected. 2. Children having recurrent episodes of recurrent URTI will be selected.

Exclusion criteria

Exclusion criteria: 1. Children having age less than 01 yrs and more than 5 years will be excluded. 2. Children having congenital anomalies, chronic pulmonary disease like pulmonary tuberculosis, chronic lung disease, in error of metabolism, chronic hematological disorders and chronic gastro intestinal disorders etc will be excluded.

Design outcomes

Primary

Measure	Time frame
Relief from Recurrent Upper Respiratory tract infection( Relief sign and symptoms)Timepoint: 45 Days	—

Secondary

Measure	Time frame
Increase immunityTimepoint: 45 Days	—

Countries

India

Contacts

Public ContactDr Harish Kumar Singhal

DR.Sarvepalli Radhakrishnan Rajasthan Ayurved University

drharish_md@yahoo.co.in9636622206

Outcome results